Friday, June 13, 2014

11 Financial Calculators Every Millennial Should Bookmark

Once you've turned your tassel at graduation and then land that first job out of college, you may feel like a financially responsible adult. But starting your career is only half the battle — you have to work at managing your money, too.
Free online financial calculators can help millennials keep their money under control.
"A calculator is just a really easy way to answer questions that you have come up, like, 'Should I rent or should I buy?'" says Alan Moore, a certified financial planner and founder of Serenity Financial Consulting in Milwaukee.
"To be able to pull up a resource and make it as easy as possible to be able to give you all the information that you need is really great," Moore says. (more)

Please share this article

End of USA Dominance? Death of the Dollar Update

Please share this article

Urban Outfitters, Inc. (NASDAQ: URBN)

Urban Outfitters, Inc., a lifestyle specialty retail company, is engaged in the retail and wholesale of general consumer products. The company operates in two segments, Retail and Wholesale. It serves its customers directly through retail stores, Websites, mobile applications, catalogs, and customer contact centers. The company operates retail stores under the Urban Outfitters, Anthropologie, Free People, Terrain, and Bhldn brands. The Urban Outfitters stores offer women’s and men’s fashion apparel, footwear, beauty, accessories, and sporting apparel and gear, as well as an eclectic mix of apartment wares and gifts to young adults aged 18 to 28; and the Anthropologie stores product assortment includes women’s casual apparel and accessories, shoes, home furnishings, and various gifts and decorative items to women aged 28 to 45.
Please take a look at the 1-year chart of URBN (Urban Outfitters, Inc.) below with my added notations:
1-year chart of URBN (Urban Outfitters, Inc.)
For the most part, URBN hasn’t taken part in the market’s rally of the last year. Instead, while trading sideways, the stock had held an important level of support at $35 (blue) for the last several months. Back in May the stock finally broke that support and fell to almost $32. The recovery over the last couple of weeks should be just a bounce before ultimately heading lower.

The Tale of the Tape: URBN had a key level of support at $35. Now that the stock has broken support, a trader might want to enter a short trade at or near the $35 level with a stop placed above that level. A break back above $35 could negate the forecast for a move lower.
Please share this article

The Howard Hughes Corporation (NYSE: HHC) Is A Bet on Las Vegas' Economic Recovery

Most people are familiar with the name Howard Hughes. The eccentric, reclusive billionaire died in 1976, but his legacy lives on in film, aviation and industry.
Today's stock pick, The Howard Hughes Corporation (NYSE: HHC), was founded by the ultra-successful businessman. The company is a major real estate management and development firm, headquartered in Dallas.
The firm has been bought and sold several times. Most recently, it was spun off as its own entity from General Growth Properties (NYSE: GGP) in 2010.
Since the spinoff, HHC has exploded. The aggressive uptrend started in January 2012, with shares more than tripling in value from around $45 to just below $150 currently.
HHC Stock Chart
The Federal Reserve's accommodative, easy money policies helped fuel this real estate company's rally, and I think there is more upside ahead. (more)
Please share this article

Alkermes Plc (NASDAQ: ALKS)

Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYRA/FAMPYRA to treat multiple sclerosis; BYDUREON to treat type II diabetes; VIVITROL for alcohol and opioid dependence; TRICOR, LIPANTHYL, LIPIDIL, and SUPRALIP to lower cholesterol; ZANAFLEX for muscle spasticity; AVINZA for moderate to severe pain; EMEND to treat nausea associated with chemotherapy and surgery; and FOCALIN XR and RITALIN LA for attention deficit and hyperactivity disorder.
Please take a look at the 1-year chart of ALKS (Alkermes Public Limited Company) below with my added notations:
1-year chart of ALKS (Alkermes Public Limited Company)
After rallying all the way into February, ALKS cooled off a bit in March. During the last 3 months the stock has created a clear resistance level at $48, while also forming an up-trending level of support as well. At some point the stock has to break one of those levels.

The Tale of the Tape: ALKS is wedged between two levels. A short trade could be made on a break of the trendline with a stop placed above the entry. However, if the stock were to break above the $48 resistance traders might want to look to get long on the stock instead.
Please share this article